62 results about "Nephrology" patented technology

The invention discloses an integrated nephrology urinary sediment microscopy device which mainly comprises a base body, a high-speed centrifugal device, a liquid taking telescopic device and a microscopy device body. The high-speed centrifugal device is embedded into the base body, the liquid taking telescopic device is connected on the upper portion of the base body through a vertical column and a horizontal supporting plate, the microscopy device body is connected on the upper portion of the horizontal supporting plate through a vertical supporting plate, a first liquid guide protection sleeve and a second liquid guide protection sleeve are longitudinally, bilaterally and parallelly arranged in the inner middle of the liquid taking telescopic device and sleeve a liquid supernatant guide pipe and a urinary sediment guide pipe in a penetrated manner, one end of the liquid supernatant guide pipe is connected with a waste liquid bottle, and the upper end of the urinary sediment guide pipe is communicated with a double-layer slide in the microscopy device body. The device is reasonable in design and convenient to operate, and working efficiency can be greatly improved.

The invention provides a platform convenient for doctor management and patient self-supervision, and aims to assist a patient to know a health condition and remind the patient to timely go back to a hospital for follow-up visit. The platform has main functions of patient archiving, examination index input, follow-up visit plan and rehabilitation plan pushing and reminding, related follow-up visit data analysis and the like, and provides online expert consultation and wardmate communication, thereby facilitating self-management and self-supervision of the patient. While follow-up visit and diagnosis and treatment process management is covered, data accumulated in an operation process is subjected to statistical analysis, so that big data value is comprehensively reflected and powerful data support and decision support are provided for clinic scientific and research of nephrology departments. The follow-up visit is taken as a center; for the patient with the chronic kidney disease, the follow-up visit is performed in the way; the problem that a kidney disease assistant in China at present takes no count of the follow-up visit is solved; the burden of a doctor and the frequency of going to the hospital for the patient are reduced; and a few unnecessary expenses are saved.

A method for distinguishing between kidney dysfunctions in a mammal, including pre-renal azotemia, an acute renal injury that may progress to acute renal failure, and chronic kidney disease, using a urinary or circulating NGAL assay result that is compared to a predetermined NGAL cutoff level, and a single serum or plasma creatinine measurement. Typically the single creatinine measurement cannot distinguish acute renal injury from chronic kidney disease or pre-renal azotemia, a single measurement of urinary NGAL, combined with the single serum or plasma creatinine measurement, has sufficient sensitivity and specificity to distinguish acute renal injury from normal function, prerenal azotemia, and chronic kidney disease and predicts poor inpatient outcomes. Patients admitted to the emergency department of the hospital with any of acute kidney injury, prerenal azotemia, chronic kidney disease, or even normal kidney function, can be evaluated based on the single measurements of urinary or circulating NGAL, and serum or plasma creatinine. Urinary NGAL level is highly predictive of clinical outcomes, including nephrology consultation, dialysis, and admission to the intensive care unit.

The present invention relates to the field of nephrology. More specifically, the present invention provides compositions and methods useful for the study and treatment of acute kidney injury. In one embodiment, the present invention provides a knockout animal whose genome comprises a deletion of exon 2 and exon 3 of kelch-like ECH-associated protein 1 (KEAP1) in T-cells. In another embodiment, a method for treating a subject diagnosed with AKI comprising the steps of (a) isolating T-cells from the subject; (b) activating Nrf2 expression in the isolated T-cells; and (c) administering the T-cells back to the subject.

The invention relates to a peritoneum dialysis locator for nephrology. The locator comprises a dialysis outer tube, an outer suction cup is arranged in the middle of the dialysis outer tube, a sealingring is hingedly mounted on the inner side of the upper portion of the outer suction cup, the inner side of the sealing ring is in contact with the dialysis outer tube, the bottom surface of the outer suction cup is hingedly provided with a circle of positioning ring, a large sealing ring is fixedly mounted on the outer side of the bottom surface of the positioning ring, two uniformly distributedannular grooves are respectively formed in the bottom surface of the middle of the positioning ring, the annular grooves are respectively provided with cooperating air bags, the bottom surfaces of the air bags are fixedly provided with circles of sealing strips, a first adhesive layer is fixedly mounted on the inner side of the bottom surface of the positioning ring, an inclined piston tube is fixedly mounted on the left side of the outer suction cup, a through groove is formed in the life side of the middle of the piston tube, a moving block is arranged in the through hole, and the moving block can move along the through groove. The locator has reasonable structural design, simple installation, time and labor saving and firm fixing, an inner suction cup and the outer suction cup are double-fixed, the fixing effect is good, double sealing improves air tightness of fixing, and the air leakage or the poor fixing effect is avoided.

A pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties is described. The composition contains active proteases attached to a gel or to a mixture of a gel with a water-soluble polymer, said attachment being achieved with the help of radiation, preferably with the help of gamma-radiation or a flow of accelerated electrons. As the proteases the composition contains proteases which are stable at a temperature of up to 70 DEG C, preferably at 30-40 DEG C, for instance such as subtilysine, trypsin, chemotrypsin, papain or streptokinase. The gel is preferably polyethylene glycol gel, dextran gel, or polyglycane gel, and the water-soluble polymer is polyethylene glycol, polyvinyl alcohol, dextran or polyglycane. The method of preparing said composition and its use are also disclosed. <??>Advantages: the claimed composition is noted for a broad range of application and can be used in cardiology, nephrology, surgery, rheumatology, gynecology and gastroenterology.

The invention discloses a nephrology nursing device with a massage function, which comprises an airbag, a controller is fixedly installed on the left side of the bottom of the airbag, an inflatable tube is fixedly installed on the top of the airbag, and a controller is fixedly installed on the inflatable tube. A motor box is fixedly installed on the front surface of the airbag, and the top of the inner cavity of the motor box is fixedly installed with a dust removal box, a cooling box and a battery in sequence from left to right, and both sides of the inner cavity of the motor box are fixedly installed There are slide rails, slide bars matching with the slide slots are arranged in the slide slots of the slide rails, and massage blocks are fixedly installed at opposite ends of the two slide bars. The nephrology nursing device with massage function achieves the effect of driving the massage block to move through the improvement of the motor box, thereby facilitating the massage of the patient, relieving the pain of the patient and speeding up the recovery of the patient, improving the device. The efficiency of use is convenient for users and the efficiency of nursing care is improved.

The invention discloses a system and a method for automatically generating a nutrition treatment scheme of a renal failure patient. The method comprises the following steps: acquiring first user information; according to the first user information, obtaining first medical record information, the first medical record information comprises a first test result, and the first test result is nephrology examination test data; obtaining a first patient grade according to the first test result; according to the first medical record information, obtaining a first food taboo disease which is not a kidney disease; inputting the first patient level and the firstfood taboo disease into a scheme generation model to obtain a first treatment scheme; obtaining a first dietary habit according to the first user information; and obtaining a first nutrition treatment scheme according to the first treatment scheme and the first dietary habit. The technical problems that in the prior art, a nutrition treatment scheme for a patient with chronic renal failure is single, only afood taboo requirement is given, but guidance of a specific recipe is lacked, the patient executes the scheme blindly, nutrition imbalance of the patient is possibly caused, and recovery is not facilitated are solved.

The invention provides a woven reinforced degradable polyurethane elastomer artificial blood vessel and a preparation method thereof. The inner layer of the artificial blood vessel adopts activated H2N-PEG-COOH, heparin and (Mpa)-GGGGGREDV polypeptide to treat a C-PEEUU-NH2 electrospun nanofiber tubular stent to obtain a C-PEEUU-PEG-Hep / REDV tubular stent, the middle layer adopts a woven reinforced layer of nanofiber yarns woven by dissolving and mixing one or more master batches of PLGA, PDO and PGA according to a mass ratio, and the outer layer is a macroporous layer prepared by thermally induced phase separation. The woven reinforced degradable polyurethane elastomer artificial blood vessel provided by the invention can be used for tissue regeneration and construction of cardiovascularand cerebrovascular diseases, the preparation method is simple and efficient, the price is low, and the prepared artificial blood vessel has resilience, compliance, bursting strength and biocompatibility matched with autologous vascular tissues. The artificial blood vessel has no hypersensitivity to a human body in a transplantation operation, has affinity with blood and peripheral tissues in thehuman body, and has a good application prospect in repair operations of cardiology surgery, nephrology surgery and brain surgery.

The invention discloses a medicine for treating sepsis in nephrology, which is prepared from the following raw materials in parts by weight: 2-8 parts of rhubarb, 3-10 parts of scutellaria baicalensis, 4-10 parts of salvia miltiorrhiza, and 3-9 parts of red peony , 7‑15 parts of Panax notoginseng, 4‑15 parts of Citrus aurantium, 3‑10 parts of Pulsatilla chinensis, and 5‑15 parts of Patrinia. The medicine for treating sepsis prepared by the nephrology department of the invention can effectively improve the treatment effect and has no toxic or side effects and adverse reactions. The preparation adopts the step-by-step method of preparing extracted powder and mixing, and the preparation method is simple and novel.

The invention discloses a medical nephrology dialysis device which comprises a machine frame and a dialysis device. The top of the machine frame is provided with a blood outlet tube, and the blood outlet tube passes into the machine frame, the top of the machine frame is provided with a blood inlet tube, the blood inlet tube passes into the machine frame, the upper right corner of the machine frame is provided with a push rod, and the push rod is closely connected with the machine frame. The medical nephrology dialysis device is reasonable in design, a roller is mounted at the bottom of the machine frame, and a roller fixator is mounted outside the roller. The device can be pushed to move through the roller. After the device stops moving, the roller is fixed through a roller fixing device,the fixation and movement of the device are facilitated, medical workers' workload is reduced, and the problem that it is inconvenient to move the device is solved.

The invention discloses a peritoneal dialysis device for nephrology. The device comprises a circular base, a collecting groove is formed in the left end of the upper surface of the circular base, theinner side surface of the collecting groove is provided with a second dialysis bag, the middle of the upper surface of the circular base is provided with a telescopic rod, the telescopic rod is in screwed connection with a positioning bolt through a threaded hole formed in the middle of the outer side surface, hooks are arranged on the upper end of the outer side surface of the telescopic rod, thenumber of the hooks is four, and the four hooks are evenly distributed on the outside surface of the telescopic rod; the peritoneal dialysis device has a compact structure, convenient operation and small occupied space for use, and can effectively prevent a dialysis hole on a dialysis tube from being blocked and wrapped by intra-abdominal structures such as omentum majus and the like, a locking universal wheel is in combination with a push rod so that the device can conveniently move, the setting of the hooks facilitates the hanging of a first dialysis bag, and the setting of the telescopic rod enables the first dialysis bag to be conveniently adjusted for lifting and lowering.

The invention discloses a nephrology auxiliary therapeutic instrument, which relates to the technical field of medical equipment. The nephrology auxiliary therapeutic instrument comprises a movable chair, a supporting frame and electromagnetic wave searchlights. The movable chair has a chair back which comprises a supporting layer and a therapeutic layer in sequence from front to back. The supporting layer and the therapeutic layer are laminated and fixedly connected on vertical columns of the chair back, supporting frames are fixed on the supporting layer, and the electromagnetic wave searchlights are fixed on the therapeutic layer. Each supporting frame comprises connecting rods, a supporting rod and limiting blocks, one end of each connecting rod is hinged and connected with one vertical column of the chair back, the other end of each connecting rod is hinged and connected with the supporting rod, and the connecting rods and the supporting rod form a double-crank mechanism. Two pairs of the double-crank mechanisms are formed, and are mounted on the two vertical columns of the chair back separately. The limiting blocks are positioned under hinged parts of the connecting rods and the vertical columns, and are fixedly connected to the inner sides of the vertical columns. The nephrology auxiliary therapeutic instrument can ensure that a patient is safe and cannot be burnt when the nephrology auxiliary therapeutic instrument is in use, and the patient can reach a comfortable and relaxed state without causing muscle and bone fatigue.